Jpmorgan Chase & CO Nkarta, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NKTX
# of Institutions
124Shares Held
66.2MCall Options Held
142KPut Options Held
43.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$34.9 Million0.96% of portfolio
-
Boxer Capital, LLC San Diego, CA5.61MShares$18.1 Million1.84% of portfolio
-
Commodore Capital LP New York, NY4.15MShares$13.4 Million2.2% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$13.1 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.8MShares$12.3 Million0.47% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $157M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...